GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a prominent focus in medical studies, largely due to its impressive impact on treating diseases such as type 2 diabetes and excess body fat. New trials have shown that in addition to glucose management, GLP-1 agoni